Hunt Jonathan Robert, Chief Accounting Officer at Perspective Therapeutics ($CATX), made one open market purchase of company shares in the last 365 days, totaling about $22,300. His most recent buy occurred on November 13, 2025. This ranks 3,735th among 4,983 individual insiders in our database, where the average purchase is $1.5 million across 3.29 transactions. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Accounting Officer | A | Stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 74,337,990 | 9999.99% | 0.12% |
| Nov. 13, 2025 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Accounting Officer | P | Common Stock | 11000 | $2.03 | 59,800.0000 | 74,337,990 | 22.54% | 0.01% |
| March 3, 2025 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Accounting Officer | A | Stock option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 2400 | $3.60 | 38,800.0000 | 0 | 6.59% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 10000 | $3.88 | 48,800.0000 | 0 | 25.77% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 29 | $3.94 | 36,400.0000 | 0 | 0.08% | 0.00% |
| Nov. 25, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 400 | $3.55 | 36,371.0000 | 0 | 1.11% | 0.00% |
| June 20, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | A | Stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 1800 | $9.82 | 35,971.0000 | 0 | 5.27% | 0.00% |
| May 31, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 13006 | $1.40 | 329,716.0000 | 0 | 4.11% | 0.00% |
| May 31, 2024 | Perspective Therapeutics, Inc. | $CATX | Hunt Jonathan Robert | Chief Financial Officer | P | Common Stock | 12000 | $1.40 | 341,716.0000 | 0 | 3.64% | 0.00% |